SCHEMBL6867915

SCHEMBL6867915

COC(=O)c1cccc(NC(=O)N[C@H]2CC[C@@H](Nc3nc4c(c(N(C)C)n3)CCCC4)CC2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.49
CXCR3 P49682 2/20 0.49
NPC1 O15118 3/20 0.47
RAB9A P51151 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
PKM P14618 1/20 0.45
ALOX15 P16050 1/20 0.45
MCHR1 Q99705 7/20 0.45
ADRA2A P08913 6/20 0.45
ADRA1A P35348 1/20 0.45
HRH1 P35367 1/20 0.45
HTR2B P41595 1/20 0.45
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
BPTF Q12830 1/20 0.42
GSK3B P49841 1/20 0.42
CSNK2A1 P68400 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6867921 1.00 EPHX2 (0.49) EPHX2CXCR3NPC1RAB9ASMN1; SMN2
SCHEMBL6880607 0.92 PKM (0.55) CXCR3NPC1SMN1; SMN2PKMALOX15
SCHEMBL6880600 0.92 PKM (0.55) CXCR3NPC1SMN1; SMN2PKMALOX15
SCHEMBL6873580 0.92 GSK3B (0.53) EPHX2CXCR3NPC1RAB9ASMN1; SMN2
SCHEMBL6873572 0.92 GSK3B (0.53) EPHX2CXCR3NPC1RAB9ASMN1; SMN2
SCHEMBL6876788 0.92 NPC1 (0.47) EPHX2NPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL6876802 0.92 NPC1 (0.47) EPHX2NPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL6873409 0.91 EPHX2 (0.43) EPHX2CXCR3NPC1SMN1; SMN2MCHR1
SCHEMBL6873414 0.91 EPHX2 (0.43) EPHX2CXCR3NPC1SMN1; SMN2MCHR1
SCHEMBL6868638 0.89 EPHX2 (0.54) EPHX2NPC1RAB9ASMN1; SMN2MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed